Immuron Limited · ASX:IMC
Immuron — FY2026 Earnings Presentation
6 slides from Immuron's earnings presentation, Aug 28, 2026
Slide 1: FY26 Preliminary Results
FY26 PRELIMINARY RESULTS S t e v e n Ly d e a m o r e - C E O NASDAQ: IMRN ASX: IMC 1
Slide 2: Safe Harbor Statement
SAFE HARBOR STATEMENT C e r t a i n s t a t e m e nt s m a d e i n t h i s p re s e nt a t i o n a re fo r wa rd - l o o k i n g s t a t e m e nt s a n d a re b a s e d o n I m m u ro n ’s c u r re nt ex p e c t a t i o n s , e s t i m a t e s a n d p ro j e c t i o n s . Wo rd s s u c h a s “a nt i
Slide 3: FY26 Financial Achievements
FY26 Financial Achievements United States Sales Global Sales Australian Sales Revenue Revenue Revenue $1.8m $7.7m $5.8m Up 7% Up 6% Up 10% Up 13% in $USD Gross Profit Margin Net Profit Cash 64.5% $(3.8)m $9.0m 0.9% $1.4m $6.2m1 decline improvement improvement 3 1. $3.0 million was held in Term Depos
Slide 4: FY26 Clinical Achievements and Operational Highlights
FY26 Clinical Achievements and Operational Highlights New U.S. FDA approval Travelan® Department of IMM-529 n=851 trial Defense IND completed subaward Strategic reset Engaged Pullan New product launch aimed at Consulting to in Australia profitability and support partnering reduced cash burn IMM-529
Slide 5: FY27 Outlook
FY27 Outlook Continued Travelan® Geographic sales Portfolio expansion sales growth expansion Continued Cash to fund Partnering update improvement in operations through for IMM-529 profitability and FY27 – FY28 reduced cash burn 5
Slide 6: Steven Lydeamore, Chief Executive Officer, Immuron Limited
STEVEN LYDEAMORE CHIEF EXECUTIVE OFFICER IMMURON LIMITED CONTACT INFORMATION: EMAIL: STEVE@IMMURON.COM PHONE: AUSTRALIA: +61 438 027 172 IMMURON INVESTOR HUB COMMUNICATION AND CONTENT INCLUDING ANNOUNCEMENTS AND CORPORATE RESEARCH
Immuron — FY2026 Earnings Presentation on 6ix